The epidemiological profile of infections with multidrug‐resistant Pseudomonas aeruginosa and Acinetobacter species

Paterson, David L. (2006). The epidemiological profile of infections with multidrug‐resistant Pseudomonas aeruginosa and Acinetobacter species. In: Clinical Infectious Diseases. Symposium on Serious Infections in the Intensive Care Unit - Pseudomonas Aeruginosa and Acinetobacter Baumannii, Pittsburg, PA, U.S.A., (S43-S48). May, 2004. doi:10.1086/504476


Author Paterson, David L.
Title of paper The epidemiological profile of infections with multidrug‐resistant Pseudomonas aeruginosa and Acinetobacter species
Conference name Symposium on Serious Infections in the Intensive Care Unit - Pseudomonas Aeruginosa and Acinetobacter Baumannii
Conference location Pittsburg, PA, U.S.A.
Conference dates May, 2004
Proceedings title Clinical Infectious Diseases   Check publisher's open access policy
Journal name Clinical Infectious Diseases   Check publisher's open access policy
Place of Publication Chicago, IL U.S.A.
Publisher University of Chicago Press
Publication Year 2006
Sub-type Fully published paper
DOI 10.1086/504476
ISSN 1058-4838
Volume 43
Issue Supp. 2
Start page S43
End page S48
Total pages 6
Language eng
Abstract/Summary Isolates of Pseudomonas aeruginosa or Acinetobacter species that are resistant to all, or almost all, commercially available antibiotics are now prevalent worldwide. Typically, these strains are recovered from patients in intensive care units who have ventilator‐associated pneumonia. “Panresistant” strains can be defined as strains that are resistant to all β‐lactam and quinolone antibiotics recommended as empirical therapy for ventilator‐associated pneumonia. These strains are well adapted to the hospital environment—molecular epidemiological studies have frequently revealed that only 1 or 2 clones caused outbreaks in intensive care units. However, panresistant strains may also be selected by antibiotic use. Given the lack of antibiotic options to treat infection with panresistant strains, enhanced surveillance for these organisms is necessary at unit‐specific, institutional, and national levels.
Subjects 110309 Infectious Diseases
1108 Medical Microbiology
1115 Pharmacology and Pharmaceutical Sciences
1117 Public Health and Health Services
Keyword Pseudomonas aeruginosa
Acinetobacter
Antibiotic reistance
Intensive care
β‐lactam
Quinolones
Q-Index Code E1

 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 147 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 212 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Wed, 27 Jan 2010, 11:31:07 EST by Macushla Boyle on behalf of Royal Brisbane Clinical School